Logan Stone Capital’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Logan Stone Capital’s Portfolio BMEZ Stock Details BMEZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-41,330	Closed	-$593K	–	163
2026 Q1	$593K	Buy	41,330 +19,593	+90%	+$291K	0.16%	79
2025 Q4	$327K	Buy	+21,737	New	+$326K	0.08%	115
2024 Q3	–	Sell	-115,244	Closed	-$1.77M	–	133
2024 Q2	$1.77M	Buy	+115,244	New	+$1.75M	0.46%	61
2024 Q1	–	Sell	-279,830	Closed	-$4.1M	–	147
2023 Q4	$4.1M	Buy	+279,830	New	+$3.91M	0.83%	42
2023 Q1	–	Sell	-338,129	Closed	-$5.22M	–	166
2022 Q4	$5.22M	Buy	338,129 +84,373	+33%	+$1.31M	1.95%	7
2022 Q3	$3.79M	Buy	253,756 +75,999	+43%	+$1.26M	2.49%	9
2022 Q2	$2.92M	Buy	177,757 +96,680	+119%	+$1.66M	2.15%	8
2022 Q1	$1.63M	Buy	+81,077	New	+$1.68M	1.17%	21

Other funds holding BMEZ

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

SCM

Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return

Logan Stone Capital's BMEZ Position: Q2 2026 in Review

Logan Stone Capital sold out of BlackRock Health Sciences Trust II (BMEZ) in Q2 2026, closing a stake of 41,330 shares — an estimated $593K sold.

Logan Stone Capital first reported a position in BMEZ in Q1 2022 and held it in 8 quarters. The position peaked at $5.22M in Q4 2022. 89 funds tracked by Wall St. Rank hold BMEZ as of Q2 2026.

Logan Stone Capital reported no remaining BlackRock Health Sciences Trust II position as of Q2 2026 after selling out during the quarter.
Logan Stone Capital sold 41,330 BlackRock Health Sciences Trust II shares in Q2 2026, an estimated $593K.
Logan Stone Capital first reported a position in BlackRock Health Sciences Trust II in Q1 2022 and held it in 8 quarters.
Logan Stone Capital's BlackRock Health Sciences Trust II position peaked at $5.22M in Q4 2022.
89 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q2 2026.

Based on Logan Stone Capital's 13F filing for Q2 2026, filed 14 Aug 2026.